Arbor Biotechnologies raised $215M Series B venture round, led by Frank Yu.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Private | — |
TCG CrossoverLEAD | Venture Capital | — |
TriWise CapitalLEAD | Private | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Corporate Venture Capital | — |
| Private | — |
| Hedge Fund | — |
| Private | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$289M
Top Valuation
-
Arbor Biotechnologies raised $215M in a Series B round.
The round was announced on 11/09/21.
The round was led by Frank Yu, Chen Yu, Temasek.